Related references
Note: Only part of the references are listed.Blockade of Dopamine D4 Receptors Attenuates Reinstatement of Extinguished Nicotine-Seeking Behavior in Rats
Yijin Yan et al.
NEUROPSYCHOPHARMACOLOGY (2012)
The Secrets of a Successful Clinical Trial: Compliance, Compliance, and Compliance
Pal Czobor et al.
MOLECULAR INTERVENTIONS (2011)
β-arrestin-mediated receptor trafficking and signal transduction
Sudha K. Shenoy et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Genetics of dopamine receptors and drug addiction: a comprehensive review
Bernard Le Foll et al.
BEHAVIOURAL PHARMACOLOGY (2009)
Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence
Frank J. Vocci et al.
CURRENT OPINION IN PSYCHIATRY (2009)
Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals
Roberta Kahn et al.
DRUG AND ALCOHOL DEPENDENCE (2009)
Modafinil for the treatment of cocaine dependence
Ann L. Anderson et al.
DRUG AND ALCOHOL DEPENDENCE (2009)
G Protein-coupled Receptor Kinase-2 Constitutively Regulates D2 Dopamine Receptor Expression and Signaling Independently of Receptor Phosphorylation
Yoon Namkung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A homogeneous enzyme fragment complementation-based beta-arrestin translocation assay for high-throughput screening of G-protein-coupled receptors
Xiaoning Zhao et al.
JOURNAL OF BIOMOLECULAR SCREENING (2008)
Pharmacokinetics of 6-hydroxybuspirone and its enantiomers administered individually or following buspirone administration in humans
Randy C. Dockens et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2007)
Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia:: A randomized, double-blind, placebo-controlled study
Tomiki Sumiyoshi et al.
SCHIZOPHRENIA RESEARCH (2007)
6-hydroxybuspirone is a major active metabolite of buspirone:: Assessment of pharmacokinetics and 5-hydroxytryptamine1A receptor occupancy in rats
Harvey Wong et al.
DRUG METABOLISM AND DISPOSITION (2007)
Serotonin and psychostimulant addiction:: Focus on 5-HT1A-receptors
Christian P. Mueller et al.
PROGRESS IN NEUROBIOLOGY (2007)
Novelty seeking involved in mediating the association between the dopamine D4 receptor gene exon III polymorphism and heavy drinking in male adolescents: results from a high-risk community sample
Manfred Laucht et al.
BIOLOGICAL PSYCHIATRY (2007)
Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence
Ahmed Elkashef et al.
DRUG AND ALCOHOL DEPENDENCE (2006)
Pharmacokinetics of a newly identified active metabolite of buspirone after administration of buspirone over its therapeutic dose range
Randy C. Dockens et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats
ZX Xi et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus
SS Negus et al.
DRUG AND ALCOHOL DEPENDENCE (2003)
The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers
SR Wachtel et al.
DRUG AND ALCOHOL DEPENDENCE (2002)
The impact of impulsivity on cocaine use and retention in treatment
FG Moeller et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2001)
An open study of buspirone augmentation of neuroleptics in patients with schizophrenia
P Sirota et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine
E Nann-Vernotica et al.
PSYCHOPHARMACOLOGY (2001)
Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans
M Haney et al.
PSYCHOPHARMACOLOGY (2001)
Dopamine D-3 receptor agents as potential new medications for drug addiction
B Le Foll et al.
EUROPEAN PSYCHIATRY (2000)
Share Paper
